open access
Vol 56, No 3 (2022)
Response to Letter to the Editors
Submitted: 2022-03-04
Accepted: 2022-03-21
Published online: 2022-04-08
Get Citation
‘Primary progressive multiple sclerosis overlapping with anti-GAD and anti-Hu antibodies positive neurological syndromes’ — clinical considerations
1
Affiliations- Department of Neurology, 10th Military Research Hospital and Polyclinic, Bydgoszcz, Poland
open access
Vol 56, No 3 (2022)
Responses to Letter to the Editors
Submitted: 2022-03-04
Accepted: 2022-03-21
Published online: 2022-04-08
Abstract
Not available
Abstract
Not available
Get Citation
About this articleTitle
‘Primary progressive multiple sclerosis overlapping with anti-GAD and anti-Hu antibodies positive neurological syndromes’ — clinical considerations
Journal
Neurologia i Neurochirurgia Polska
Issue
Article type
Response to Letter to the Editors
Pages
292-292
Published online
2022-04-08
Page views
4255
Article views/downloads
398
DOI
Pubmed
Bibliographic record
Neurol Neurochir Pol 2022;56(3):292-292.
Authors
Łukasz Rzepiński
References (5)- Štourač P, Bednářová J, Pavelek Z, et al. Primary progressive multiple sclerosis overlapping with anti-GAD and anti-Hu antibodies positive neurological syndromes. Neurol Neurochir Pol. 2021 [Epub ahead of print].
- Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018; 17(2): 162–173.
- Petzold A. Applying the 2017 McDonald diagnostic criteria for multiple sclerosis. Lancet Neurol. 2018; 17(6): 496–497.
- Sirbu CA, Budisteanu M, Falup-Pecurariu C. Monoclonal antibodies - a revolutionary therapy in multiple sclerosis. Neurol Neurochir Pol. 2020; 54(1): 21–27.
- Wawrzyniak S, Rzepiński Ł. Is there a new place for mitoxantrone in the treatment of multiple sclerosis? Neurol Neurochir Pol. 2020; 54(1): 54–61.
